Atherectomy Device Market (By Devices Type: Atherectomy Devices, Angioplasty Balloon Catheters, Stents, Intravascular Ultrasound Catheters, Optical Coherence Tomography Catheters, Drug-Coated Balloons, Embolic Protection Devices, Thrombectomy Devices, Aortic Stent Grafts, Endovascular Grafts, Laser Atherectomy Devices, Orbital Atherectomy Systems, and Others; By Application; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Atherectomy Devices Market
5.1. COVID-19 Landscape: Atherectomy Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Atherectomy Devices Market, By Devices Type
8.1. Atherectomy Devices Market Revenue and Volume, by Devices Type, 2024-2033
8.1.1 Atherectomy Devices
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Angioplasty Balloon Catheters
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Stents (Bare-Metal, Drug-Eluting, Bioresorbable)
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Intravascular Ultrasound (IVUS) Catheters
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Optical Coherence Tomography (OCT) Catheters
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
8.1.6. Drug-Coated Balloons
8.1.6.1. Market Revenue and Volume Forecast (2021-2033)
8.1.7. Embolic Protection Devices
8.1.7.1. Market Revenue and Volume Forecast (2021-2033)
8.1.8. Thrombectomy Devices
8.1.8.1. Market Revenue and Volume Forecast (2021-2033)
8.1.9. Aortic Stent Grafts
8.1.9.1. Market Revenue and Volume Forecast (2021-2033)
8.1.10. Endovascular Grafts
8.1.10.1. Market Revenue and Volume Forecast (2021-2033)
8.1.11. Laser Atherectomy Devices
8.1.11.1. Market Revenue and Volume Forecast (2021-2033)
8.1.12. Orbital Atherectomy Systems
8.1.12.1. Market Revenue and Volume Forecast (2021-2033)
8.1.13. Rotational Atherectomy Devices
8.1.13.1. Market Revenue and Volume Forecast (2021-2033)
8.1.14. Directional Atherectomy Devices
8.1.14.1. Market Revenue and Volume Forecast (2021-2033)
8.1.15. Chronic Total Occlusion (CTO) Devices
8.1.15.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Atherectomy Devices Market, By Application
9.1. Atherectomy Devices Market Revenue and Volume, by Application, 2024-2033
9.1.1. Peripheral Artery Disease (PAD) Treatment Devices
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Coronary Artery Disease (CAD) Intervention Devices
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Carotid Artery Disease Intervention Devices
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Renal Artery Disease Intervention Devices
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
9.1.5. Aortic Atherosclerosis Intervention Devices
9.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Atherectomy Devices Market, By End-user
10.1. Atherectomy Devices Market Revenue and Volume, by End-user, 2024-2033
10.1.1. Cardiac Catheterization Labs
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Interventional Radiology Departments
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Vascular Surgery Centers
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Cardiology Clinics
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Academic Research Institutions
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Atherectomy Devices Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.2.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.3.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Devices Type (2021-2033)
11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
Chapter 12. Company Profiles
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Boston Scientific Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. BD
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cardinal Health Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Koninklijke Philips NV
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Medtronic Plc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Terumo Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Avinger
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Cardiovascular Systems
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Ra Medical Systems
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample